Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea flag South Korea · Delayed Price · Currency is KRW
62,000
-100 (-0.16%)
At close: Dec 5, 2025

Celltrion Pharm Revenue

Celltrion Pharm had revenue of 85.55B KRW in the quarter ending March 31, 2021, with 92.73% growth. This brings the company's revenue in the last twelve months to 274.73B, up 53.21% year-over-year. In the year 2020, Celltrion Pharm had annual revenue of 233.57B with 34.61% growth.

Revenue (ttm)
274.73B
Revenue Growth
+53.21%
P/S Ratio
9.82
Revenue / Employee
837.59M
Employees
328
Market Cap
2,696.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2020233.57B60.06B34.61%
Dec 31, 2019173.51B26.63B18.13%
Dec 31, 2018146.88B11.02B8.11%
Dec 31, 2017135.86B31.05B29.62%
Dec 31, 2016104.81B30.08B40.25%
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 5,504.84B
Celltrion 3,895.99B
ALTEOGEN 202.18B
ABL Bio 88.44B
SK Biopharmaceuticals 675.41B
Yuhan 2,136.67B
LigaChem Biosciences 159.27B
Peptron 6.19B
Revenue Rankings